Enzyme–substrate reporters for evaluation of substrate specificity of HIF prolyl hydroxylase isoforms


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

An organism naturally responds to hypoxia via stabilization of hypoxia-inducible factor (HIF). There are three isoforms of HIFα subunits whose stability is regulated by three isozymes of HIF prolyl hydroxylase (PHD1-3). Despite intense studies on recombinant enzyme isoforms using homogeneous activity assay, there is no consensus on the PHD iso-form preference for the HIF isoform as a substrate. This work provides a new approach to the problem of substrate specificity using cell-based reporters expressing the enzyme and luciferase-labeled substrate pair encoded in the same expression vector. The cell is used as a microbioreactor for running the reaction between the overexpressed enzyme and substrate. Using this novel approach, no PHD3 activity toward HIF3 was demonstrated, indirectly pointing to the hydroxylation of the second proline in 564PYIP567 (HIF1) catalyzed by this isozyme. The use of “paired” enzyme–substrate reporters to evaluate the potency of “branched tail” oxyquinoline inhibitors of HIF PHD allows higher precision in revealing the optimal structural motif for each enzyme isoform.

Авторлар туралы

A. Osipyants

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Ресей, Moscow, 117997

N. Smirnova

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Ресей, Moscow, 117997

A. Khristichenko

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Ресей, Moscow, 117997

D. Hushpulian

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Ресей, Moscow, 117997

S. Nikulin

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Ресей, Moscow, 117997

T. Chubar

Lomonosov Moscow State University, Chemistry Faculty

Email: igazaryan@gmail.com
Ресей, Moscow, 119991

A. Zakhariants

Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Ресей, Moscow, 109451

V. Tishkov

Lomonosov Moscow State University, Chemistry Faculty; Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Ресей, Moscow, 119991; Moscow, 109451

I. Gazaryan

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology; Lomonosov Moscow State University, Chemistry Faculty

Хат алмасуға жауапты Автор.
Email: igazaryan@gmail.com
Ресей, Moscow, 117997; Moscow, 119991

A. Poloznikov

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Ресей, Moscow, 117997


© Pleiades Publishing, Ltd., 2017

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>